N-terminal Pro–B-Type natriuretic peptide for risk assessment in patients with atrial fibrillation

Hijazi, Z. et al. (2013) N-terminal Pro–B-Type natriuretic peptide for risk assessment in patients with atrial fibrillation. Journal of the American College of Cardiology, 61(22), pp. 2274-2284. (doi:10.1016/j.jacc.2012.11.082)

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:McMurray, Professor John
Authors: Hijazi, Z., Wallentin, L., Siegbahn, A., Andersson, U., Christersson, C., Ezekowitz, J., Gersh, B.J., Hanna, M., Hohnloser, S., Horowitz, J., Huber, K., Hylek, E.M., Lopes, R.D., McMurray, J.J.V., and Granger, C.B.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
Journal Name:Journal of the American College of Cardiology
Publisher:Elsevier Inc.
ISSN:0735-1097

University Staff: Request a correction | Enlighten Editors: Update this record